Navigation Links
ChemImage Works to Improve Existing Methods of Imaging Untreated Fingerprints on Paper Substrates
Date:6/4/2009

PITTSBURGH, June 4 /PRNewswire/ -- Scientists at ChemImage are pleased to report significant improvements in the ability to enhance contrast of untreated fingerprints on paper substrates. Using the CONDOR(TM) Hyperspectral Imaging System, application scientists at ChemImage have been able to apply new developments in software and hardware configurations resulting in the enhancement of more ridge detail of untreated latent prints on paper.

"The results are very promising," said John Belechak, Chief Operating Officer at ChemImage, "To compare the images of these untreated fingerprints to those that we've seen in previous publications demonstrates a noteworthy step forward in the science of latent print examination."

The CONDOR Hyperspectral Imaging System utilizes liquid crystal imaging technology, which provides fingerprint examiners with the ability to nondestructively enhance contrast between the print residue and the substrate. When combined with the powerful ChemImage Xpert(TM) software package, users have access to a significant number of image filtering algorithms. This software becomes extremely important when examining fingerprints on dark substrates or substrates with complex backgrounds.

"While our CONDOR Hyperspectral Imaging System can be used to compliment many processing techniques for fingerprints, it can also provide a means of examining untreated prints, especially if the evidence may contain DNA or includes sensitive documents or art," said Belechak.

About ChemImage

ChemImage Corporation, headquartered in Pittsburgh, is a world leader in Chemical Imaging technologies; provides instrumentation, software, lab services and expert consulting to government, industrial and academic organizations. ChemImage offers these products and services for a range of applications including defense, security, pharmaceuticals, forensics and biomedical diagnostic research. Its state-of-the-art Chemical Imaging technology can help to reveal critical chemical and biological information about processes, products, and forensic evidence.

    Contact:
    Linda Batykefer
    Marketing Coordinator
    ChemImage
    412-241-7335 ext 269
    batykefer@chemimage.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE ChemImage Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions
2. Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed
3. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
4. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
5. ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks
6. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
7. MichBio Announces Annual Business Meeting Keynote and Pre-Meeting Workshop
8. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
9. SenesTech Scientists Attend International Workshop on Fertility in New Zealand
10. Proximity Systems LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
11. Enrichment of Genomic Loci for Targeted Sequencing Application Is Focus of 2009 AGBT Conference Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics ... applications subject to the existing policy. AMIA recommended that NIH earmark funding for ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
Breaking Biology Technology:
(Date:12/22/2016)... , December 22, 2016 SuperCom (NASDAQ: ... secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors ... SuperCom, has been selected to implement and deploy a community-based supportive ... Northern California , further expanding its presence in the ... This new ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... , Dec. 15, 2016 ... driving experience, health wellness and wellbeing (HWW), ... one in three new passenger vehicles begin ... recognition, gesture recognition, heart beat monitoring, brain ... monitoring, facial monitoring, and pulse detection. These ...
Breaking Biology News(10 mins):